Tesamorelin – Stabilised GHRH Analogue for Research

Tesamorelin is an advanced synthetic analogue of human growth hormone-releasing hormone, also known as GHRH or growth hormone-releasing factor. It contains the complete 44-amino-acid sequence of human GRF with a specialised N-terminal trans-3-hexenoyl modification. This molecular modification supports improved resistance to rapid enzymatic degradation and gives Tesamorelin a more stable research profile than naturally occurring GHRH. Its clearly defined structure makes Tesamorelin particularly relevant for professional laboratory studies involving GHRH receptor activity, pituitary signalling, endogenous growth hormone release, the GH–IGF-1 axis and stabilised peptide development. Tesamorelin is supplied as a premium lyophilised research material in a securely sealed vial with clear batch information, professional packaging and fast order processing from Peptides Divas.

Caratteristiche principali del prodotto

• Synthetic human GHRH analogue
• Complete 44-amino-acid peptide sequence
• Also known by the research designation TH9507
• Specialised N-terminal hexenoyl modification
• Designed for improved molecular stability
• Relevant for GHRH receptor research
• Suitable for pituitary signalling studies
• Useful for GH and IGF-1 pathway research
• Fornito come materiale di ricerca liofilizzato
• Informazioni chiare sul prodotto specifiche per lotto
• Imballaggio sicuro e discreto
• Spedizione europea rapida e tracciabile.

What Is Tesamorelin?

Tesamorelin is a synthetic peptide based on the complete amino-acid sequence of naturally occurring human growth hormone-releasing hormone. Natural GHRH is produced in the hypothalamus and communicates with specialised receptors located on somatotroph cells within the anterior pituitary. This signalling system is involved in regulating the synthesis and pulsatile release of endogenous growth hormone. Naturally occurring GHRH is rapidly broken down by enzymes. Tesamorelin contains an N-terminal trans-3-hexenoyl group attached to its tyrosine residue, creating a stabilised GHRH analogue suitable for extended peptide and receptor research.

Molecular Structure

Tesamorelin contains 44 amino acids and retains the complete sequence of human GRF. Its structural characteristics include:

• Complete human GRF 1–44 sequence
• N-terminal tyrosine residue
• Trans-3-hexenoyl molecular modification
• C6 carbon chain containing a double bond
• Stabilised synthetic peptide structure
• GHRH receptor agonist activity
• Approximate molecular weight of 5.1 kDa
• Commonly prepared and analysed as an acetate salt

The hexenoyl modification differentiates Tesamorelin from unmodified human GHRH and shorter GHRH fragments.

Ricerca sul recettore GHRH

Tesamorelin is primarily studied in relation to the growth hormone-releasing hormone receptor. The GHRH receptor is a G-protein-coupled receptor expressed mainly on pituitary somatotroph cells. Activation of this receptor initiates intracellular signalling associated with growth hormone synthesis and secretion. Potential areas of laboratory research include:

• legame del recettore GHRH
• Attivazione del recettore
• Interazioni ligando-recettore
• Segnalazione dell'AMP ciclico
• Intracellular calcium pathways
• Pituitary somatotroph activity
• Internalizzazione del recettore
• Sensibilità del recettore
• Relazioni dose-risposta
• Comparative GHRH analogue pharmacology

The exact experimental conditions and analytical methods should be established by the qualified laboratory conducting the research.

Pituitary Signalling Research

The anterior pituitary is an important endocrine signalling centre responsible for releasing several protein and peptide hormones. Tesamorelin may be relevant for controlled laboratory studies involving:

• Somatotroph-cell signalling
• Endogenous growth hormone release
• Pulsatile hormone secretion
• Pituitary receptor expression
• Trasduzione del segnale intracellulare
• Hormone-release kinetics
• Hypothalamic–pituitary communication
• Meccanismi di feedback endocrino
• Comparative pituitary-cell assays
• GHRH-mediated cellular responses

Tesamorelin stimulates the GHRH pathway rather than acting as recombinant growth hormone itself.

GH–IGF-1 Axis Research

The growth hormone and insulin-like growth factor 1 axis forms an interconnected endocrine signalling network. GHRH receptor activation in the pituitary can influence endogenous growth hormone secretion. Growth hormone subsequently participates in signalling associated with IGF-1 production and broader endocrine feedback systems. Tesamorelin may therefore be studied in relation to:

• Growth hormone pulsatility
• GH secretion patterns
• IGF-1-associated signalling
• Endocrine feedback loops
• Hypothalamic–pituitary communication
• Analisi dei biomarcatori ormonali
• Metabolic signalling pathways
• Protein-turnover mechanisms
• Comparative endocrine models
• Time-dependent hormone responses

These pathways describe areas of scientific interest and should not be interpreted as guaranteed effects from a non-pharmaceutical research material.

Stabilised Peptide Research

The N-terminal hexenoyl modification makes Tesamorelin particularly relevant for research into peptide stabilisation and molecular engineering. Potential research topics include:

• Resistance to enzymatic degradation
• N-terminal peptide modification
• Estensione dell'emivita molecolare
• Peptide clearance
• Relazioni struttura-attività
• Long-acting peptide design
• Peptide pharmacokinetics
• Modified GHRH analogues
• Stabilità molecolare
• Peptide formulation development

Researchers may compare Tesamorelin with native GHRH, sermorelin, Modified GRF 1–29 or other GHRH-related compounds.

Tesamorelin Versus Sermorelin

Tesamorelin and sermorelin are both related to human GHRH, but they are not identical compounds.

Caratteristica	Tesamorelin
Sequenza peptidica	Human GRF 1–44
lunghezza del peptide	44 amino acids
Modificazione molecolare	N-terminal trans-3-hexenoyl group
Primary receptor	recettore GHRH
Profilo di ricerca	Stabilised full-length GHRH analogue
Alternative designation	TH9507

Sermorelin generally refers to the shorter GHRH 1–29 sequence and does not contain the same hexenoyl modification.

Tesamorelin Versus CJC-1295

Tesamorelin and CJC-1295 are both synthetic GHRH-related peptides, but their structures and stabilisation strategies differ. Tesamorelin contains the full 44-amino-acid human GRF sequence with an N-terminal hexenoyl modification. CJC-1295 with DAC uses a different modified peptide sequence and an albumin-binding Drug Affinity Complex. Researchers should not treat these compounds as interchangeable and should verify the exact product identity through batch-specific analytical documentation.

Ricerca sulle vie metaboliche

The GH–IGF-1 axis interacts with multiple metabolic and endocrine systems. Tesamorelin may be relevant for laboratory models involving:

• Segnalazione correlata ai lipidi
• Vie metaboliche dell'omeostasi del glucosio
• Protein metabolism
• Hepatic signalling
• Adipocyte biology
• Endocrine–metabolic communication
• Cellular energy regulation
• Hormone-responsive gene expression
• Metabolic biomarker analysis
• Comparative peptide research

Research results can vary according to the biological model, concentration, exposure duration and analytical method.

Potenziali applicazioni di ricerca

Tesamorelin may be suitable for controlled scientific research involving:

• GHRH receptor pharmacology
• Pituitary somatotroph signalling
• Endogenous growth hormone secretion
• Growth hormone pulsatility
• GH–IGF-1 axis research
• Hypothalamic–pituitary communication
• Meccanismi di feedback endocrino
• Peptide stabilisation
• N-terminal molecular modification
• Relazioni struttura-attività
• Segnalazione metabolica
• Caratterizzazione analitica dei peptidi
• Analisi cromatografica
• Analisi mediante spettrometria di massa
• Test di stabilità e degradazione
• Comparative GHRH analogue research

The receiving laboratory is responsible for determining and validating appropriate concentrations, controls and analytical procedures.

Ricerca analitica

Tesamorelin may be suitable for professional analytical applications involving:

• Cromatografia liquida ad alte prestazioni
• Cromatografia liquida-spettrometria di massa
• Conferma dell'identità del peptide
• Analisi del peso molecolare
• Verifica della sequenza degli amminoacidi
• Valutazione della purezza
• Test di stabilità
• Profilazione del degrado
• Valutazione della solubilità
• Materiale di riferimento
• Compatibilità della formulazione
• Sviluppo di metodi analitici

Because Tesamorelin contains an N-terminal lipid modification, analytical methods should be validated specifically for this compound.

Specifiche del prodotto

Caratteristiche del prodotto	Informazioni
Nome del prodotto	Tesamorelin
Alternative designation	TH9507
Categoria di prodotto	Peptide sintetico per la ricerca
Tipo composto	Stabilised GHRH analogue
lunghezza del peptide	44 amino acids
basi strutturali	Complete human GRF 1–44 sequence
Modificazione molecolare	N-terminal trans-3-hexenoyl group
Obiettivo primario della ricerca	recettore GHRH
Principale percorso di ricerca	Asse dell'ormone della crescita e dell'IGF-1
Approximate molecular weight	5.1 kDa
Modulo	Materiale di ricerca liofilizzato
Presentazione	Fiala da ricerca sigillata in modo sicuro
Documentazione	Informazioni analitiche specifiche per lotto
Confezione	Imballaggio sicuro e discreto
Applicazione prevista	Ricerca scientifica, analitica e di laboratorio

Formato di ricerca liofilizzato

Tesamorelin is supplied as a lyophilised research material in a securely sealed vial. Lyophilisation removes moisture and helps support peptide stability during controlled storage and transportation. Minor differences in physical appearance may occur because of product quantity, production conditions and residual moisture. Physical appearance alone should not be used to establish product identity, purity or analytical quality. Researchers should review the documentation associated with the applicable batch before beginning laboratory work.

Qualità e trasparenza del prodotto

Peptides Divas focuses on clearly displayed product specifications, professional handling and batch-level traceability. Available analytical information may include:

• Identificazione del prodotto
• Sequenza peptidica
• Numero di lotto
• Purezza dichiarata
• Analisi HPLC
• Dati di spettrometria di massa
• Molecular-weight information
• Informazioni sui test
• Aspetto del prodotto
• Consigli per la conservazione

Ciò fornisce ai ricercatori informazioni chiare e tracciabili relative al lotto di prodotto in questione.

Informazioni di archiviazione

Store Tesamorelin in its original sealed packaging according to the conditions displayed on the product label and applicable batch documentation. Protect the research material from:

• Luce solare diretta
• Calore eccessivo
• Umidità
• Contaminazione
• Imballaggio danneggiato
• Fluttuazioni ripetute della temperatura
• Esposizione non necessaria all'aria

Il laboratorio ricevente è responsabile della definizione di procedure adeguate di preparazione, manipolazione e conservazione per il proprio specifico protocollo di ricerca.

Why Choose Tesamorelin?

Tesamorelin provides a clearly defined and stabilised full-length GHRH analogue for advanced receptor and endocrine research. Key research advantages include:

• Complete 44-amino-acid human GRF sequence
• Specialised N-terminal hexenoyl modification
• Rilevante per gli studi sui recettori del GHRH
• Suitable for pituitary signalling research
• Useful for GH–IGF-1 axis models
• Valuable for peptide-stability analysis
• Suitable for comparative GHRH research
• Comoda confezione liofilizzata
• Informazioni chiare sul prodotto specifiche per lotto

Perché ordinare da Peptides Divas?

Peptides Divas combina materiali di ricerca accuratamente selezionati con un servizio rapido, affidabile e professionale. I clienti beneficiano di:

• Specifiche del prodotto chiaramente visualizzate
• Informazioni analitiche specifiche per lotto
• Elaborazione rapida degli ordini
• Imballaggio sicuro e discreto
• Opzioni di spedizione tracciabili
• Attenta protezione della fiala
• Assistenza clienti reattiva
• Consegna affidabile in Europa

Choose Tesamorelin from Peptides Divas for advanced laboratory research involving GHRH receptor activity, pituitary signalling, the GH–IGF-1 axis and stabilised peptide design. For laboratory research use only. Not intended for human or veterinary use.